Germany
· Delayed Price · Currency is EUR Heidelberg Pharma AG Statistics
Total Valuation
FRA:HPHA has a market cap or net worth of EUR 148.20 million. The enterprise value is 127.68 million.
| Market Cap | 148.20M |
| Enterprise Value | 127.68M |
Important Dates
The next estimated earnings date is Thursday, July 10, 2025.
| Earnings Date | Jul 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 46.60M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.47% |
| Shares Change (QoQ) | -5.70% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 9.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.63 |
| PB Ratio | 5.91 |
| P/TBV Ratio | 9.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.13 |
| EV / Sales | 18.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.57 |
Financial Position
The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.15 |
| Quick Ratio | 4.78 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -592.23 |
Financial Efficiency
Return on equity (ROE) is -59.35% and return on invested capital (ROIC) is -40.11%.
| Return on Equity (ROE) | -59.35% |
| Return on Assets (ROA) | -26.48% |
| Return on Invested Capital (ROIC) | -40.11% |
| Return on Capital Employed (ROCE) | -51.33% |
| Revenue Per Employee | 65,264 |
| Profits Per Employee | -198,337 |
| Employee Count | 105 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.15 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.31% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 75.42 |
| Average Volume (20 Days) | 4,145 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:HPHA had revenue of EUR 6.85 million and -20.83 million in losses. Loss per share was -0.45.
| Revenue | 6.85M |
| Gross Profit | 5.06M |
| Operating Income | -24.25M |
| Pretax Income | -20.87M |
| Net Income | -20.83M |
| EBITDA | -23.51M |
| EBIT | -24.25M |
| Loss Per Share | -0.45 |
Balance Sheet
The company has 20.68 million in cash and 151,890 in debt, giving a net cash position of 20.53 million.
| Cash & Cash Equivalents | 20.68M |
| Total Debt | 151,890 |
| Net Cash | 20.53M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.06M |
| Book Value Per Share | 0.54 |
| Working Capital | 34.18M |
Cash Flow
In the last 12 months, operating cash flow was -27.42 million and capital expenditures -507,555, giving a free cash flow of -27.93 million.
| Operating Cash Flow | -27.42M |
| Capital Expenditures | -507,555 |
| Free Cash Flow | -27.93M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 73.80% |
| Operating Margin | -353.88% |
| Pretax Margin | -304.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:HPHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.47% |
| Shareholder Yield | -1.47% |
| Earnings Yield | -14.05% |
| FCF Yield | -18.85% |
Stock Splits
The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.
| Last Split Date | Nov 7, 2017 |
| Split Type | Forward |
| Split Ratio | 1.0464082038 |
Scores
FRA:HPHA has an Altman Z-Score of -6.89. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.89 |
| Piotroski F-Score | n/a |